Abhishek Kumar
ShakeKumarMD
My 1st *Tweetorial*! We investigated cost-effectiveness of adding SABR to standard tx for pts with oligometastatic dz. Manuscript out in #RedJournal!TL;DR – Adding SABR was robustly cost-effective under a wide
Read more